Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program – three randomized, controlled, phase IIb studies — Mihai Gheorghiade (2011) | RDL Network
Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program – three randomized, controlled, phase IIb studies
Mihai Gheorghiade, Stephen J. Greene, Gerasimos Filippatos, Erland Erdmann, Roberto Ferrari, Phillip D. Levy, Aldo Maggioni, Christina Nowack, Alexandre Mebazaa
Burkert Pieske, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Andrea Scalise, Katharina Müller, Lothar Roessig, Mihai Gheorghiade
Burkert Pieske, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Andrea Scalise, Katharina Müller, Lothar Roessig, Mihai Gheorghiade
Gerasimos Filippatos, Aldo Maggioni, Carolyn S.P. Lam, Elisabeth Pieske‐Kraigher, Javed Butler, John A. Spertus, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Andrea‐Viviana Scalise, Katharina Mueller, Lothar Roessig, Luke Bamber, Mihai Gheorghiade, Burkert Pieske
Mihai Gheorghiade, Stephen J. Greene, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Katharina Müller, Lothar Roessig, Burkert Pieske
Discussion(0)
No comments yet. Be the first to comment.